Series E funding
Arthrosi Therapeutics Raises $153 Million in Series E to Advance Gout and Inflammatory Disease Treatment
October 16, 2025
byArthrosi Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering innovative small-molecule therapies for gout and other inflammatory diseases, has successfully raised...
Read MoreArthrosi Therapeutics Secures $153 Million in Series E Funding to Redefine Treatment for Gout and Inflammatory Diseases
October 16, 2025
byArthrosi Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering next-generation therapies for inflammatory diseases, has successfully raised $153 million in Series...
Read MoreCorvus Energy Secures $60 Million Series E Funding to Accelerate Maritime Electrification
October 16, 2025
byCorvus Energy, a global leader in marine battery energy storage systems, has raised $60 million in Series E funding, led...
Read More

